HYPER CORPORATION INC.

Highlights Hyper Corporation Inc.

Equities

A065650

KR7065650004

End-of-day quote Korea S.E. Other stock markets 03:30:00 05/06/2024 am IST			5-day change	1st Jan Change
1,404 ^KRW	-1.54%		-5.96%	+42.83%

30/05	Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc.	CI
30/05	AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd..	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc.	30/05	CI
AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd..	30/05	CI
Medifron DBT Co., Ltd. completed the acquisition of 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd..	30/05	CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..	05/04	CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.	05/04	CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.	05/04	CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.	28/03	CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion	16/02	CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors	22/22/22	CI
J&Giant Spice Private Equity Partnership agreed to acquire SJ CORE CO.,LTD from Medifron DBT Co., Ltd. for KRW 22 billion.	30/20/30	CI
Brain M&R Co., Ltd. acquired 2.83% stake in Medifron DBT Co., Ltd. from Hyeon-Sang Mook for KRW 2.8 billion.	07/17/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer